JBPC> Vol.4 No.2, May 2013

Fermented papaya preparation halts the progression of non-alcoholic steatohepatitis in rats

DownloadDownload as PDF (Size:505KB)  HTML    PP. 84-90  

ABSTRACT

Non-alcoholic steatohepatitis (NASH) can progress to cirrhosis or hepatocellular carcinoma. Oxidative stress is implicated in NASH progression. Fermented papaya preparation (FPP) has oxygen radical scavenging activity and is effective in oxidative stress-related diseases. We investigated the effects of FPP on NASH progression using a rat NASH model. Plasma biochemical parameters and lipid peroxidation in the liver were elevated in NASH rats. Histologically, the liver of NASH rats showed liver fibrosis, mitochondrial dysfunction and over-expression of microsomal CYP2E1. Myeloperoxidase activity and nuclear factor-kappaB activation were also markedly increased in NASH. Oral administration of FPP ameliorated these changes in NASH rats. These results suggest that FPP halts NASH progression through its anti-oxidative and antiinflammatory properties.

KEYWORDS


Cite this paper

Murakami, S. , Takayama, F. , Egashira, T. , Imao, M. and Mori, A. (2013) Fermented papaya preparation halts the progression of non-alcoholic steatohepatitis in rats. Journal of Biophysical Chemistry, 4, 84-90. doi: 10.4236/jbpc.2013.42012.

References

[1] Ludwig J., Viggiano, T.R., McGill, D.B. and Oh, B.J. (1980) Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings, 55, 434-438.
[2] Day, C.P. and James, O. (1998) Steatohepatitis: A tale of “two hits’’? Gastroenterology, 114, 842-845. doi:10.1016/S0016-5085(98)70599-2
[3] Takayama, F., Hobara, N., Nakamoto, K., Ohro, M., Yoshida, N., Takeda, A., Kawasaki, H. and Egashira, T. (2006) Construction of a non-alcoholic steatohepatitis model induced by fatty liver and nitrite administration. Journal of Pharmacological Science, 100, 164.
[4] Kazuo, N., Fusako, T., Mitsumasa, M., Yuki, H., Toru, E., Tetsuya, O., Hiromu, K. and Akitane, M. (2009) Beneficial effects of fermented green tea extract in a rat model of non-alcoholic steatohepatitis. Journal of Clinical Biochemistry & Nutrition, 44, 239-246. doi:10.3164/jcbn.08-256
[5] Fusako, T., Kazuo, N., Hiromu, K., Mitsumasa, M., Toru, E., Keiji, U., Azusa, H., Shigeru, O. and Akitane, M. (2009) Beneficial effects of vitis coignetiae pulliat leaves on nonalcoholic steatohepatitis in a rat model. Acta Medicne Okayama, 63, 105-111.
[6] Pak, W., Takayama, F., Hasegawa, A., Mankura, M., Egashira, T., Ueki, K., Nakamoto, K., Kawasaki, H. and Mori, A. (2012) Water extract of Vitis coignetiae Pulliat leaves attenuates oxidative stress and inflammation in progressive NASH rats. Acta Medicine Okayama, 66, 317-327.
[7] Takayama, F., Nakamoto, K., Totani, N., Yamanushi, T., Kabuto, H., Kaneyuki, T. and Mankura, M. (2010) Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis. Journal of Oleo Science, 59, 407-414. doi:10.5650/jos.59.407
[8] Pak, W., Takayama, F., Mine, M., Nakamoto, K., Kodo, Y., Mankura, M., Egashira, T., Kawasaki, H. and Mori, A. (2012) Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis. Journal of Clinical Biochemistry & Nutrition, 51, 227-234.
[9] Osato, J.A., Santiago, L.A., Remo, G.M., Cuadra, M.S. and Mori, A. (1993) Antimicrobial and antioxidant activi- ties of unripe papaya. Life Science, 53, 1383-1389. doi:10.1016/0024-3205(93)90599-X
[10] Mehdipour, S., Yasa, N., Dehghan, G., Khorasani, R., Mohammadirad, A., Rahimi, R. and Abdollahi, M. (2006) Antioxidant potentials of Iranian Carica papaya juice in vitro and in vivo are comparable to alpha-tocopherol. Phytother Research, 20, 591-594. doi:10.1002/ptr.1932
[11] Rajkapoor, B., Jayakar, B., Kavimani, S. and Murugesh, N. (2002) Effect of dried fruits of Carica papaya Linn on hepatotoxicity. Biological & Pharmaceutical Bulletin, 25, 1645-1646. doi:10.1248/bpb.25.1645
[12] Nakamura, Y., Morimitsu, Y., Uzu, T., Ohigashi, H., Murakami, A., Naito, Y., Nakagawa, Y., Osawa, T. and Uchida, K. (2000) A glutathione S-transferase inducer from papaya: Rapid screening, identification and structure-activity relationship of isothiocyanates. Cancer Letters, 157, 193-200. doi:10.1016/S0304-3835(00)00487-0
[13] Noda, Y., Murakami, S., Mankura, M. and Mori, A. (2008) Inhibitory effect of fermented papaya preparation on hydroxyl radical generation from methylguanidine. Journal of Clinical Biochemistry & Nutrition, 43, 185-190. doi:10.3164/jcbn.2008062
[14] Imao, K., Wang, H., Komatsu, M. and Hiramatsu, M. (1998) Free radical scavenging activity of fermented papaya preparation and its effect on lipid peroxide level and super- oxide dismutase activity in iron-induced epileptic foci of rats. Biochemistry & Molecular Biology International, 45, 11-23.
[15] Imao, K., Komatsu, M., Wang, H. and Hiramatsu, M. (1999) Inhibitory effect of fermented papaya preparation on oxidative DNA damage and tissue injury in the brain formed during iron-induced epileptogenesis in rats. Journal of Brain Science, 25, 71-77.
[16] Mori, A., Yokoi, I., Noda, Y. and Willmore, L.J. (2004) Natural antioxidants may prevent posttraumatic epilepsy: A proposal based on experimental animal studies. Acta Medicine Okayama, 58, 111-118.
[17] Zhang, J., Mori, A., Chen, Q. and Zhao, B.L. (2006) Fermented papaya preparation attenuates β-amyloid precursor protein: β-amyloid-mediated copper neurotoxicity in β-amyloid precursor protein and in β-amyloid precursor Swedish mutation overexpressing SH-SY5Y cells. Neuroscience, 143, 63-72. doi:10.1016/j.neuroscience.2006.07.023
[18] Hiramoto, K., Imao, M., Sato, E., Inoue, M. and Mori A. (2008) Effect of fermented papaya preparation on dermal and intestinal mucosal immunity and allergic inflammations. Journal Science of Food Agriculture, 88, 1151-1157. doi:10.1002/jsfa.3190
[19] Shinki, M., Fusako, T., Toru, E., Mitsuko, I. and Akitane, M. (2012) Protective effect of fermented papaya preparation on stress-induced acute gastric mucosal lesion. Journal of Biophysical Chemistry, 3, 311-316. doi:10.4236/jbpc.2012.34038
[20] Leclercq, I.A. (2004) Antioxidant defence mechanisms: New players in the pathogenesis of non-alcoholic steatohepatitis? Clinical Science, 106, 235-237. doi:10.1042/CS20030368
[21] Das, K.S., Balakrishnan, V., Mukherjee, S. and Vasudevan, D.M. (2008) Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. Scandinavian Journal of Clinical & Laboratory Investigation, 68, 323-334. doi:10.1080/00365510701673383
[22] Harrison, S.A., Torgerson, S., Hayashi, P., Ward, J. and Schenker, S. (2003) Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. American Journal of Gastroenterology, 98, 2485-2490. doi:10.1111/j.1572-0241.2003.08699.x
[23] Sanyal, A.J., Campbell-Sargent, C., Mirshahi, F., Rizzo, W.B., Contos, M.J., Sterling, R.K., Luketic, V.A., Shiffman, M.L. and Clore, J.N. (2001) Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology, 120, 1183-1192. doi:10.1053/gast.2001.23256
[24] Serviddio, G., Sastre, J., Bellanti, F., Vi?a, J., Vendemiale, G. and Altomare, E. (2007) Mitochondrial involvement in non-alcoholic steatohepatitis. Molecular Aspects Medicine, 29, 22-35. doi:10.1016/j.mam.2007.09.014
[25] Kojima, H., Sakurai, S., Uemura, M., Fukui, H., Morimoto, H. and Tamagawa, Y. (2007) Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcoholism: Clinical and Experimental Research, 31, 61-66. doi:10.1111/j.1530-0277.2006.00288.x
[26] Robertson, G., Leclercq, I. and Farrell, G.C. (2001) Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. American Journal of Physiology Gastrointest Liver Physiology, 281, 1135-1139.
[27] Nieto, N., Friedman, S.L. and Cederbaum, A.I. (2002) Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells. Journal of Biological Chemistry, 22, 9853-9864. doi:10.1074/jbc.M110506200
[28] Nieto, N., Friedman, S.L. and Cederbaum, A.I. (2001) Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology, 35, 62-73. doi:10.1053/jhep.2002.30362
[29] George, J., Pera, N., Phung, N., Leclercq, I., Yun Hou, J. and Farrell, G. (2003) Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. Journal of Hepatology, 39, 756-764.
[30] Tak, P.P. and Firestein, G.S. (2001) NF-kappaB: A key role in inflammatory diseases. Journal of Clinical Investment, 107, 7-11. doi:10.1172/JCI11830
[31] Dela Pe?a, A., Leclercq, I., Field, J., George, J., Jones, B. and Farrell, G. (2005) NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology, 129, 1663-1674. doi:10.1053/j.gastro.2005.09.004
[32] Gao, Y., Song, L.X., Jiang, M.N., Ge, G.Y. and Jia, Y.J. (2008) Effects of traditional Chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Inflammation, 31, 121-132. doi:10.1007/s10753-008-9057-3
[33] Fujita, K., Nozaki, Y., Yoneda, M., Wada, K., Takahashi, H., Kirikoshi, H., Inamori, M., Saito, S., Iwasaki, T., Terauchi, Y., Maeyama, S. and Nakajima, A. (2010) Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model. Alcoholism: Clinical and Experimental Research, 34, 18-24. doi:10.1111/j.1530-0277.2008.00756.x

comments powered by Disqus

Copyright © 2014 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.